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Abstract: 
 
Background: Laparoscopic sleeve gastrectomy (LSG) is an effective operation for severe 
obesity. There is controversy as to the optimal technical approach with some advocating 
sparing of the gastric antrum (antral-preserving, AP) and others supporting commencement 
of resection close to the pylorus (antral-resecting, AR). The objective of this systematic 
review was to investigate the effect on peri-operative complications and medium-term 
outcomes of AR compared to AP. 
 
Methods: We included studies comparing AR (2 to 3cm from pylorus) with AP (> 5cm from 
pylorus) in patients undergoing primary sleeve gastrectomy for obesity. Medline, EMBASE 
and Cochrane Review databases from 1946 to April 2017 were searched for studies. Risk of 
bias within and across studies was assessed using validated scoring systems (Jadad, USPSTF 
and GRADE).  
 
Results: Eight studies, involving 619 participants, were included: six randomized controlled 
trials (RCTs) and two retrospective cohort studies. AR was associated with non-significant 
and significant improvement in weight loss at 12 and 24 month follow-up respectively (12 
months: seven studies, 574 subjects, standardized mean difference [SMD] of percentage 
excess weight loss [%EWL] 0.67 (-0.05 to 1.38); and 24 months: four studies, 412 subjects, 
SMD of %EWL 0.95 (0.32 to 1.58)), without altering risk of peri-operative bleeding, leak or de 
novo gastro-oesophageal reflux disease (GORD). Radical antral resection was associated with 
better weight loss at 24 months after surgery compared to antral preservation, without 
increased risk of surgical complications. 
 
Discussion: 
Limitations of this analysis include study bias (failure to describe method of randomization 
and/or dropouts), and imprecision due to small overall number of complications. The 
cumulative evidence is that radical antral resection leads to improved medium-term weight 
loss, with no change in surgical risk profile.  
 
Registration: 
PROSPERO: CRD42016048657 
  
 Main text: 
 
Introduction: 
 
Laparoscopic sleeve gastrectomy (LSG) is an effective operation for morbid obesity, with 
comparable short-term outcomes to Roux-en-Y gastric bypass (RYGB) for weight loss (1,2) 
and diabetes resolution (3,4).  
 
In recent years the number of LSG performed has dramatically increased; LSG was the most 
commonly performed bariatric operation in the USA in 2013 (5). Despite its popularity, the 
operation is far from standardised and practice varies widely between surgeons (6). 
 
One aspect of controversy is the extent to which the antrum is excised. Proponents of a 
radical antral resection argue that more restriction leads to better weight loss (7). They point 
out that since LSG alone is purely restrictive, unlike when it is combined with small intestinal 
bypass in duodenal switch, the restriction must be profound (8). Opponents stress the 
importance of preserving the physiological emptying mechanism of the stomach, in order to 
avoid increased intraluminal pressure (9). Consequences of raised intraluminal pressure 
could potentially include staple-line leak in the short-term and gastro-oesophageal reflux in 
the longer term (10).  
 
The objective of this systematic review and meta-analysis was to examine difference in 
complication rate and weight loss outcomes between antral-sparing (AP) and antral-excising 
(AR) LSG for obesity.  
 
Methods: 
 
Literature search: 
 
This study was performed following the Preferred Reporting Items for Systematic reviews 
and Meta-analyses (PRISMA) guidelines (11). The study has been registered with the 
Prospective Register of Systematic Reviews, PROSPERO identification code 
CRD42016048657. Study titles were searched using MEDLINE (1946 to April 2017) and 
Embase (1947 to April 2017) databases using Ovid Online (Ovid Technologies Inc, 2016) in 
May 2017. Key term combinations were as follows: ‘antr* preserv* OR antr* exc* OR antr* 
resect* OR antr* spar* OR antrectomy’ AND ‘gastr* adj5 sleeve’ AND ‘obes*’. No language 
restrictions were applied. Cochrane database and reference lists of original articles were 
additionally searched (to April 2017). Published conference abstracts were included where 
there was sufficient information provided for eligibility to be assessed. 
 
Eligibility criteria: 
 
Studies of participants undergoing primary laparoscopic sleeve gastrectomy for obesity were 
included. Studies designed to compare the difference in outcome between a radical antral 
resection (defined as commencing the staple line 2-3cm from the pylorus: AR) and an antral-
sparing resection (defined as commencing the staple line >5cm from the pylorus: AP) were 
included. Retrospective analyses of cohorts in which extent of antral resection was one of 
several technical and clinical variables were not included. 
 
Outcomes assessed were % excess weight loss (%EWL) at 12 months post-LSG, %EWL at 24 
months post-LSG, post-operative staple line bleed, staple line leak, 30-day mortality, and 
incidence of de novo gastro-oesophageal reflux disease (GORD). Studies which did not 
report any of these outcomes were excluded.  
 
Study selection: 
 
Two authors screened all titles and abstracts for relevance. Only clearly irrelevant material 
was excluded at this stage. Two authors independently screened the full texts, assessing 
eligibility for inclusion. Any differences were resolved by discussion and consensus. Where 
necessary, study data was confirmed with the corresponding author. 
 
The following data were retrieved where reported on a piloted spreadsheet: date of 
publication, study design, randomisation method, number of randomised patients, 
definition of AR/AP used by study authors, demographics including pre-operative BMI of 
patients, staple-line leaks, staple-line bleeds, 30-day post-operative mortalities, de-novo 
GORD, %EWL at 12 months, %EWL at 24 months and other outcomes. 
 
Quality assessment of studies: 
 
Risk of bias was assessed on the study level for all included studies, using the Jadad scoring 
system for randomised controlled trials (RCTs) (12) and the US Preventive services Task 
Force (USPSTF) Quality Rating Criteria for cohort studies (13). The Jadad score is a validated 
tool to assign a score between 0 (weakest) and 5 (strongest) based on the quality of study 
design and the USPSTF have validated a similar tool for case-control studies where studies 
are graded ‘good’, ‘fair’ or ‘poor’ depending on fulfilment of internal validity criteria.  
 
Risk of bias across studies was evaluated using guidance from the Grading of 
Recommendations Assessment, Development and Evaluation working group (GRADE) 
(14,15). On the basis of overall quality of evidence, confidence in each outcome measure can 
be classified into one of four levels – high, moderate, low and very low.  
 
Subgroup analysis was planned to investigate causes of heterogeneity, where found to be 
significant in initial analysis. This was planned for measures of trial quality: RCT or not, and 
Jadad score. It was also planned for other technical variables that have been associated with 
differences in likelihood of adverse outcome: bougie size and presence of staple-line 
reinforcement (SLR) (16). 
 
Statistical analysis: 
 
Meta-analysis was used to evaluate the effect of radical antral resection on %EWL at 12 
months, early complications and incidence of de novo GORD. Data was analysed on an 
intention-to-treat basis where possible. STATA 14 was used to estimate summary measures 
with 95% confidence intervals: standardised mean differences (SMD) and pooled relative 
risk (RR) for continuous and dichotomous variables respectively. As AR is considered the 
intervention, and AP the comparator, RRs are reported as AR/AP ratios.  
 
The I2-statistic was used to assess the impact of heterogeneity on the analysis. 
Heterogeneity was considered significant when I2 was greater than 50%. A random effects 
model was used to calculate the overall effect. Meta-regression to explore for the cause of 
heterogeneity, where significant, was planned. 
 
 Results: 
 
Study selection: 
The search yielded 197 articles. After de-duplication and exclusions (Figure 1), a total of 
eight studies remained which provided data for a total of 619 patients (7,10,17-22). Table 
1 summarises the participants, interventions and outcomes of eligible studies. Given the 
small number of included studies, tests for funnel plot asymmetry were not performed. 
 
Risk of bias within studies: 
Risk of bias according to the Jadad score is summarised in Table 2 for the six randomised 
controlled trials (RCTs). All RCTs scored 3 or less: this can be attributed to a lack of double-
blinding in any of the trials, and to two of the trials consisting of abstracts only, with a 
consequent lack of methodological detail (18,19).  
 
Two cohort studies were selected for inclusion (17,22). Obeidat et al analysed two 
consecutive single-centre, single-surgeon cohorts, in which there was an isolated change in 
practice from 6-cm antral resection (AP) to 2cm antral resection (AR). The two groups were 
comparable pre-operatively. Yormaz et al analysed two groups of patients for which 
operative technique was consistent apart from antral length, and who were pre-operatively 
demographically similar. In this study no information was given regarding how patients were 
allocated to the two groups but loss to follow-up reasons were given and there was no 
evidence of systemic bias. Both studies were rated as ‘good’ according to the USPSTF Quality 
Rating Criteria. 
 
Weight loss at 12 months post-surgery (12 month %EWL) (Figure 2): 
Seven studies reported on this outcome, five of which were RCTs ((7,10,18,20,21). Only 
one RCT found a statistically significant difference in 12 month %EWL and this was in favour 
of AR (10). Both cohort studies (17,22) found a statistically significant difference in favour 
of AR for this outcome. 
 
Meta-analysis for weight loss at 12 months post-surgery demonstrated non-significantly 
better weight loss for AR both with RCTs only (SMD 0.32, CI -0.02 to 0.67; p=0.68), and also 
with inclusion of the cohort studies (SMD 0.67; CI -0.05 to 1.38; p=0.67).  
For the RCT data alone there was moderate heterogeneity (I2 = 51.4%) but the effect size 
was mostly favouring or close to null. For all studies combined heterogeneity was high (I2 = 
93.4%): again both studies found effect sizes favouring the intervention, but the effect size 
of one study was very large (SMD 2.64; CI 2.20 to 3.08). Removing this study from analysis 
(Appendix 1) preserved the significant effect in favour of AR but substantially reduced 
heterogeneity (SMD 0.40, CI 0.12 to 0.69, I2 =48.2%). The residual heterogeneity could 
mainly be explained by small study size, with some contribution from study type and age of 
patients.  
 
Weight loss at 24 months post-surgery (24 month %EWL): 
Four studies reported on this outcome, two of which were RCTs (10,19) (Figure 3). Both RCTs 
found that AR was associated with increased 24 month %EWL than AP although this was 
only statistically significant in one (10). The two cohort studies (17,22) also both reported 
significantly greater 24 month %EWL with AR when compared to AP. 
 
Meta-analysis for weight loss at 24 months post-surgery demonstrated increased 24 month 
%EWL with AR (SMD 0.95; 95% CI 0.32 to 1.58; p=0.003). There was significant 
heterogeneity for both overall and RCT-only analyses. This can again be explained by 
different study type and small study size, with a low number of included studies. 
  
Incidence of staple-line leak (figure 4): 
Four studies reported incidence of staple-line leak (10,17,20,22). Three showed a trend 
towards higher risk of leak in patients undergoing AR when compared to AP, however the 
number of leaks was low (seven in total across all studies), confidence intervals were high 
and none reached statistical significance. 
 
Meta-analysis for this outcome showed no significant increased risk for leak with AR 
compared to AP (RR 1.87; 95% CI 0.46 to 7.61), with no significant heterogeneity. 
 
Incidence of staple-line bleed (figure 5): 
Five studies reported on staple-line bleed (7,10,17,20,22). No difference was seen 
between the two surgical approaches in incidence of bleed in any individual study or on 
meta-analysis (RR 1.27; CI 0.4 to 4.01). Total number of cases of bleed was low. 
 
Incidence of post-operative de novo gastro-oesophageal reflux disease (GORD): 
Three studies reported on incidence of GORD (7,10,17) (figure 6): There was no statistically 
significant difference between the two surgical techniques in terms of GORD incidence 
demonstrated in any individual study or on meta-analysis (RR 0.69; CI 0.26 to 1.82). 
 
Sub-group analysis and risk of bias across studies: 
Sub-group analysis was performed for the factor ‘RCT or not’ for the outcomes of %EWL (see 
above). Jadad score was 3 or below for all studies, and so subgroup analysis for this factor 
was omitted. The other factors initially planned for sub-group analysis (bougie size and SLR) 
showed too much variability/ insufficient group sizes for this to be useful, given the small 
overall number of eligible studies. 
 
Risk of bias across studies for each outcome measure is illustrated in table 3. 
 
Discussion: 
 
Eight studies comparing radical antral resection with antral preservation during laparoscopic 
sleeve gastrectomy for morbid obesity demonstrated a probable improved weight loss with 
AR (moderate to low quality evidence) and no evidence of difference in rate of staple-line 
bleed, leak or post-operative de novo GORD (very low quality evidence). 
 
The main strength of this analysis is that it is the first systematic review and meta-analysis of 
outcomes following the two operative strategies. The search was comprehensive, rigorous 
pre-defined meta-analysis was performed and quality of evidence has been probed using the 
GRADE approach. As sleeve gastrectomy becomes increasingly popular as a treatment for 
obesity, optimizing the operative technique according to judicious appraisal of the available 
evidence is essential. This analysis demonstrates that AR is associated with improved weight 
loss, without evidence of increased complications. This is of considerable clinical relevance 
to surgeons and patients.  
 
The main limitations of this review are those of the primary studies. Small numbers of 
patients combined with low incidence of complications leads to imprecision in outcome 
data. There was also considerable risk of bias in the included RCTs with method of 
randomization not described in several and poor detail regarding dropouts/ withdrawals. As 
with other surgical RCTs, challenges related to the complexity of surgical interventions are 
difficult to circumvent (23). In this case, the use of AR or AP is one variable which is likely 
to interact with other demographic and technical variables to give overall risk of outcome. 
Although planned, it was not possible to perform subgroup analyses to address some of 
these potential confounders because of the small numbers of studies and cases eligible for 
inclusion. 
  
In conclusion, AR is likely to be associated with improved short-medium term excess weight 
loss following sleeve gastrectomy for morbid obesity when compared with AP. Further 
research involving larger-scale RCTs are indicated.  
 
  
  
 
Figure 1: PRISMA flow diagram to illustrate study selection 
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 Figure 2: Weight loss at 12 months post-surgery  
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Figure 3: Weight loss at 24 months post-surgery
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 Figure 4: Incidence of staple-line leak 
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 Figure 5: Incidence of staple-line bleed 
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 Figure 6: Incidence of post-operative de novo gastro-oesophageal reflux disease 
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Table 1: characteristics of included studies 
Reference 
(full-
length 
paper 
unless 
otherwise 
indicated) 
Numbe
r 
treated 
Number 
completing 
study 
(number in 
interventio
n group – 
AR) 
Definition 
of 
interventio
n (AR) and 
comparator 
(AP) in cm 
from 
pylorus 
Pre-
operativ
e BMI in 
kg/m2 
mean 
(SD) 
Staple line 
reinforcemen
t 
Bougie 
size 
Mean 
%Excess 
weight 
loss (SD) 
at 12 
months 
post-
surgery 
(all 
patients
) 
Mean 
%Excess 
weight 
loss (SD) 
at 24 
months 
post-
surgery 
(all 
patients
) 
Total 
early 
mortalit
y (% of 
cases) 
Total 
Leak (% 
of 
cases) 
Total 
Bleed 
(% of 
cases) 
Total de 
novo 
GORD 
(% of 
cases) 
Jadad 
score 
Abdallah 105 105 (52) 2cm vs 6cm 51.7 (7.5) 
Not routine 38F 
57.8 
(16) 
66.5 
(12.7) 
1 (1.0) 3 (2.9) 1 (1.0) 5 (4) 3 
Elgeidie 114 106 (55) 2cm vs 6cm 44.8 
Not routine 38F 
66.1 Not 
given 
1 1 (0.9) 3 (2.7) Not 
given 
2 
Garay 
(abstract) 
30 30 (14) 2cm vs 5cm Not 
given 
Not detailed 
Not 
detaile
d 
57.7 Not 
given 
Not 
given 
Not 
given 
Not 
given 
Not 
given 
1 
Grubnik 
*(abstract
) 
45 45 (22) 2cm vs 6cm 49.6 (6.8) 
Not detailed 
Not 
detaile
d 
Not 
detailed 
56.4 0 (0) 0 (0) 0 (0) Not 
given 
1 
Michalsky 12 12 (6) 2.5cm vs 
6cm 
41.4 
Not routine 36F 
61.8 Not 
detailed 
0 (0) 0 (0) 2 (16.7) 3 (25) 2 
Obeidat 125 110 (56) 2cm vs 6cm 46.1 (7.9) 
Oversewn 38F 
72.9 
(23.5) 
73.2 
(27.3) 
0 (0) 1 (1.0) 3 (2.7) 10 (9) NA 
(cohor
t 
study) 
Pereferrer 60 59 (30) 3cm vs 8cm 51.1 
Seamguard 38F 
60.5& Not 
detailed 
0 (0) Not 
detaile
d 
Not 
detaile
d 
Not 
detaile
d 
3 
Yormaz 168 152 (84) 2cm vs 6cm 48.8 +/-
5.3 
V-loc wound 
closure device 36F 
56.3  0 (0) 2 3 Not 
detaile
d 
NA 
(cohor
t 
study) 
* No leak or bleed assumed from statement in abstract ‘no serious postoperative complications in both groups’. Author uncontactable to clarify. 
& %EWL using IDW based on Metropolitan life tables (2 calculations of EWL using different IDW were given in this paper) 
 
 
Table 2: risk of bias in included randomised controlled trials (Jadad score) 
 
Reference Described as 
randomised? 
Adequate 
method of 
randomisation? 
(One point 
deducted if 
inappropriate) 
Described 
as 
double-
blind? 
Adequate method of 
double-blinding? 
(One point deducted if 
inappropriate) 
Description of 
dropouts/ 
withdrawals? 
Jadad 
score 
Abdallah Yes Yes No No No dropouts 3 
Elgeidie Yes Yes No No Yes 3 
Garay Yes Not described No No No statement 1 
Grubnik Yes Not described No No No statement 1 
Michalsky Yes Not described No No No withdrawals 2 
Pereferrer Yes Yes No No Yes 3 
  
 Table 3: GRADE evidence profile: 
Outcome Risk of 
bias* 
Inconsistency Indirectness Imprecision** Publication 
bias 
Classification 
12 month 
%EWL 
Serious 
limitations 
Serious 
limitations 
(inconsistent 
Forrest plot 
estimates) 
No serious 
limitations 
No serious 
limitations 
Undetected Low 
24 month 
%EWL 
Serious 
limitations 
Serious 
limitations 
(heterogeneity) 
No serious 
limitations 
No serious 
limitations 
Undetected Moderate 
Staple-line 
leak 
Serious 
limitations 
No serious 
limitations 
No serious 
limitations 
Very serious 
limitations  
Undetected Very low 
Staple-line 
bleed 
Serious 
limitations 
No serious 
limitations 
No serious 
limitations 
Very serious 
limitations 
Undetected Very low  
GORD Serious 
limitations 
No serious 
limitations 
No serious 
limitations 
Very serious 
limitations 
Undetected Very low 
* For most studies there was an inadequate method of randomization (if at all) and no blinding in any study 
** For dichotomous outcomes the number of events was very low so results are imprecise 
 Appendix 1: Weight loss at 12 months post-surgery with one retrospective study (Yormaz et al) removed 
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